{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:06:42Z","timestamp":1791925602161,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Sardinian Regional Government"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.autrev.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T17:17:34Z","timestamp":1400260654000},"page":"873-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort"],"prefix":"10.1016","volume":"13","author":[{"given":"Matteo","family":"Piga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Chessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ibba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Floris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Cauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.05.005_bb0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.005_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/annrheumdis-2013-203419","article-title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.05.005_bb0015","first-page":"1","article-title":"Non-tumor necrosis factor-based biologic therapies for rheumatoid arthritis: present, future, and insights into pathogenesis","volume":"8","author":"Paula","year":"2014","journal-title":"Biogeosciences"},{"key":"10.1016\/j.autrev.2014.05.005_bb0020","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.005_bb0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","article-title":"Biologic therapies and systemic bone loss in rheumatoid arthritis","volume":"12","author":"Dimitroulas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.005_bb0030","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2012.11.009","article-title":"Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target?","volume":"12","author":"Modena","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.005_bb0035","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.autrev.2012.11.002","article-title":"Novel diagnostic approaches and cost\u2013benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease","volume":"12","author":"Roccatello","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.005_bb0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.05.005_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"Biologics-induced autoimmune diseases","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/s10165-010-0333-3","article-title":"Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis","volume":"20","author":"Kaneko","year":"2010","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0055","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1345\/aph.1Q492","article-title":"Membranous glomerulonephritis with the use of etanercept in ankylosing spondylitis","volume":"45","author":"Kaushik","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.autrev.2014.05.005_bb0060","first-page":"840","article-title":"Membranous nephropathy in rheumatoid arthritis: a case report","volume":"27","author":"Maruotti","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0065","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2014.05.005_bb0070","first-page":"137","article-title":"Nephrotic syndrome as a complication of anti-TNFalpha in a patient with rheumatoid arthritis","volume":"61","author":"den Broeder","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.autrev.2014.05.005_bb0075","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/ndt\/gfp314","article-title":"IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy","volume":"24","author":"Jacquet","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2014.05.005_bb0080","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/rheumatology\/kes403","article-title":"Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis","volume":"52","author":"Matsuo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2014.05.005_bb0085","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jbspin.2013.05.003","article-title":"Mesangial immunoglobulin (Ig)A glomerulonephritis in a patient with rheumatoid arthritis treated with abatacept","volume":"80","author":"Michel","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2014.05.005_bb0090","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2010.08.019","article-title":"Drug-induced granulomatous interstitial nephritis in a patient with ankylosing spondylitis during therapy with adalimumab","volume":"56","author":"Korsten","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2014.05.005_bb0095","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3899\/jrheum.120325","article-title":"Tumor necrosis factor-alpha inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis","volume":"39","author":"Nishimura","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14712\/18059694.2015.74","article-title":"Case\u00a01\u20132012: ANCA associated glomerulonephritis in combination with IgG4-positive mediastinal mass in a patient with ankylosing spondylitis treated with TNF alpha inhibitors","volume":"55","author":"Tosovsky","year":"2012","journal-title":"Acta Med (Hradec Kralove)"},{"key":"10.1016\/j.autrev.2014.05.005_bb0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10067-007-0712-0","article-title":"C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab","volume":"27","author":"Ashok","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0110","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2007.10.043","article-title":"ANCA-associated renal vasculitis following anti-tumor necrosis factor alpha therapy","volume":"51","author":"Simms","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2014.05.005_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.5414\/CNP62234","article-title":"Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis","volume":"62","author":"Doulton","year":"2004","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0120","first-page":"S106","article-title":"Henoch Schonlein purpura following etanercept treatment of rheumatoid arthritis","volume":"24","author":"Duffy","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0125","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jbspin.2004.05.008","article-title":"Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis","volume":"71","author":"Roux","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2014.05.005_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.rhu.0000239901.34561.5e","article-title":"Henoch\u2013Schonlein purpura after etanercept therapy for psoriasis","volume":"12","author":"Lee","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.12659\/AJCR.883841","article-title":"Appearance of ANCA \u2014 associated vasculitis under tumor necrosis factor-alpha inhibitors treatment","volume":"14","author":"Reitblat","year":"2013","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.autrev.2014.05.005_bb0140","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/RHU.0b013e3182863027","article-title":"Etanercept-induced Henoch\u2013Schonlein purpura in a patient with ankylosing spondylitis","volume":"19","author":"Rolle","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0145","first-page":"740","article-title":"Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept","volume":"32","author":"Mor","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0150","first-page":"221","article-title":"Clinical and histological features of lupus nephritis induced by anti-TNF\u03b1 therapy","volume":"4","author":"Piccolo","year":"2008","journal-title":"NDT plus"},{"key":"10.1016\/j.autrev.2014.05.005_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1741-7015-11-95","article-title":"Renal involvement in autoimmune connective tissue diseases","volume":"11","author":"Kronbichler","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2014.05.005_bb0160","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0961203313482741","article-title":"Rituximab treatment for \u2018rhupus syndrome\u2019: clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study","volume":"22","author":"Piga","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2014.05.005_bb0165","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/art.1780400417","article-title":"Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy","volume":"40","author":"Mustila","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.005_bb0170","first-page":"87","article-title":"Newer immunomodulating drugs in rheumatoid arthritis may precipitate glomerulonephritis","volume":"55","author":"Kemp","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ckj\/sfs081","article-title":"Minimal-change disease secondary to etanercept","volume":"5","author":"Koya","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2014.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00296-009-1016-2","article-title":"Permanent renal loss following tumor necrosis factor alpha antagonists for arthritis","volume":"30","author":"Chen","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2014.05.005_bb0185","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MCG.0b013e3181fae913","article-title":"Development of the nephrotic syndrome during treatment of Crohn's disease with adalimumab","volume":"45","author":"Gupta","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5414\/CNP70240","article-title":"Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximab","volume":"70","author":"Hatakeyama","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0195","first-page":"447","article-title":"Spontaneous resolution of lupus nephritis following withdrawal of etanercept","volume":"43","author":"Yahya","year":"2013","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.autrev.2014.05.005_bb0200","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","article-title":"Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey","volume":"7","author":"De Bandt","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.05.005_bb0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jbspin.2006.02.010","article-title":"Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France","volume":"73","author":"Saint Marcoux","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2014.05.005_bb0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2014.05.005_bb0215","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.semarthrit.2007.08.003","article-title":"Drug-induced lupus due to anti-tumor necrosis factor alpha agents","volume":"37","author":"Costa","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.05.005_bb0220","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11926-008-0072-z","article-title":"Vasculitis induced by tumor necrosis factor-targeted therapies","volume":"10","author":"Ramos-Casals","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2014.05.005_bb0225","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4049\/jimmunol.162.2.684","article-title":"Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12","volume":"162","author":"Becher","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.05.005_bb0230","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrrheum.2011.35","article-title":"Autoimmune-like syndromes during TNF blockade: does infection have a role?","volume":"7","author":"Prinz","year":"2011","journal-title":"Nat Rev Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214001244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T01:53:25Z","timestamp":1689213205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214001244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1568997214001244"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}